A re-evaluation, using reams of proprietary data from the original 2001 study, shows that the conclusion that Paxil was safe and effective for teens with depression was flawed. The new re-appraisal team calls for more such studies of older data to shed more light on possibly-flawed conclusions.
The association between maternal use of antidepressants, especially selective serotonin reuptake inhibitors (SSRIs) during pregnancy, and birth defects in newborns and infants, has been the topic of much discussion in recent years. A new study, published in the BMJ, finds a small increased risk of two SSRIs (Paxil/paroxetine and Prozac/fluoxetine) with some birth defects, but not others (including the most commonly used SSRI,